The University of Glasgow's cancer research centre on the Garscube estate, home to Andrew Biankin's pancreatic cancer genomics group and the Precision-Panc programme that ran the PRIMUS trials through NHS Greater Glasgow and Clyde.
The Wolfson Wohl Cancer Research Centre houses the University of Glasgow's Institute of Cancer Sciences at Garscube, Bearsden. Andrew Biankin, Regius Chair of Surgery, leads pancreatic cancer genomics there and directs ICGC-ARGO; the Precision-Panc master protocol (ISRCTN14879538), sponsored by NHS Greater Glasgow and Clyde, profiled pancreatic tumours at 27 UK sites between December 2017 and March 2022 to route patients into the PRIMUS trials, and its team co-authored the STARPAC2 protocol. Clinical care for the West of Scotland is at Glasgow Royal Infirmary and the Beatson.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to University of Glasgow, including child institutions. 815 works · 9,010 citations · 81% open access · 8% clinical trials · 4% reviews.
Shares Andrew Biankin, Pancreatic ductal adenocarcinoma and the tags uk, pancreatic.
Shares Pancreatic ductal adenocarcinoma and the tags uk, pancreatic.
Shares Pancreatic ductal adenocarcinoma and the tags uk, pancreatic.
Shares Pancreatic ductal adenocarcinoma and the tags uk, pancreatic.
Shares Glasgow Royal Infirmary, Pancreatic ductal adenocarcinoma and the tags uk, pancreatic.
Shares Precision-Panc, Pancreatic ductal adenocarcinoma and the tag uk.
Shares Precision-Panc, Pancreatic ductal adenocarcinoma and the tag uk.
Shares Precision-Panc, Pancreatic ductal adenocarcinoma and the tag uk.